http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-200002102-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
filingDate 1999-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b67af01fb7b21935b653b5dbc9e0616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f25bf45fcf16a949fa5d0f157d816c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b9a5a54cdb98add3c96a918fb97809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31a92a32e15bf7c8b3c3f4acaa9f07c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac1587690b74321a953fb83689fc3b9
publicationDate 2000-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-200002102-T2
titleOfInvention Prolonged-release tiagabine formulations with reduced side effects
abstract They are long-term release tiagabine formulations that show less side effects when administered to a patient.
priorityDate 1998-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504541

Total number of triples: 34.